Banoxantrone (dihydrochloride)
- Product Name
- Banoxantrone (dihydrochloride)
- CAS No.
- 252979-56-9
- Chemical Name
- Banoxantrone (dihydrochloride)
- Synonyms
- Banoxantrone 2HCl;AQ4N dihydrochloride;Banoxantrone dihydrochloride >=98% (HPLC);Banoxantrone dihydrochloride, 10 mM in DMSO;Banoxantrone dihydrochloride (AQ4N dihydrochloride);Banoxantrone dihydrochloride (AQ4N), Topoisomerase II inhibitor;1,4-Bis[[2-(dimethyloxidoamino)ethyl]amino]-5,8-dihydroxy-9,10-anthracenedione dihydrochloride;9,10-Anthracenedione, 1,4-bis[[2-(dimethyloxidoamino)ethyl]amino]-5,8-dihydroxy-, hydrochloride;2,2'-((5,8-Dihydroxy-9,10-dioxo-9,10-dihydroanthracene-1,4-diyl)bis(azanediyl))bis(N,N-dimethylethanamine oxide) dihydrochloride;2,2'-((5,8-Dihydroxy-9,10-dioxo-9,10-dihydroanthracene-1,4-diyl)bis(azanediyl))bis(N,N-dimethylethanamine oxide) dihydrochloride
- CBNumber
- CB73339609
- Molecular Formula
- C22H29ClN4O6
- Formula Weight
- 480.95
- MOL File
- 252979-56-9.mol
Banoxantrone (dihydrochloride) Property
- storage temp.
- Store at -20°C, protect from light, stored under nitrogen
- solubility
- Soluble to 50 mM in water and to 25 mM in DMSO
- form
- Solid
- color
- Blue to dark blue
- Water Solubility
- Water : 25 mg/mL (48.32 mM)
Hazard and Precautionary Statements (GHS)
- Symbol(GHS)
-
- Signal word
- Danger
- Hazard statements
-
H302Harmful if swallowed
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
H350May cause cancer
- Precautionary statements
-
P201Obtain special instructions before use.
P202Do not handle until all safety precautions have been read and understood.
P261Avoid breathing dust/fume/gas/mist/vapours/spray.
P280Wear protective gloves/protective clothing/eye protection/face protection.
P301+P312IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P302+P352IF ON SKIN: wash with plenty of soap and water.
P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.
N-Bromosuccinimide Price
- Product number
- SML1854
- Product name
- Banoxantrone dihydrochloride
- Purity
- ≥98% (HPLC)
- Packaging
- 5 mg
- Price
- $135
- Updated
- 2025/07/31
- Product number
- SML1854
- Product name
- Banoxantrone dihydrochloride
- Purity
- ≥98% (HPLC)
- Packaging
- 25 mg
- Price
- $437
- Updated
- 2025/07/31
- Product number
- B129285
- Product name
- BanoxantroneDihydrochloride
- Packaging
- 2.5mg
- Price
- $250
- Updated
- 2021/12/16
- Product number
- CS-6986
- Product name
- Banoxantronedihydrochloride
- Purity
- 99.17%
- Packaging
- 5mg
- Price
- $96
- Updated
- 2021/12/16
- Product number
- CS-6986
- Product name
- Banoxantronedihydrochloride
- Purity
- 99.17%
- Packaging
- 10mg
- Price
- $168
- Updated
- 2021/12/16
Banoxantrone (dihydrochloride) Chemical Properties,Usage,Production
Uses
Banoxantrone (AQ4N) is a hypoxia-activated prodrug of topoisomerase II inhibitor AQ4 (Bioreductive AQ4 precursor). studies have shown that its has also exhibited anti-tumor efficacy in vivo when combined with oxic cell cytotoxins.
Biological Activity
Banoxantrone (AQ4N) is a hypoxia-activated prodrug of topoisomerase II inhibitor AQ4 (Bioreductive AQ4 precursor).', 'Banoxantrone dihydrochloride enhances the anti-tumor effect caused by radiation.
in vivo
Banoxantrone (200 mg/kg) significantly enhances the tumor growth delay caused by radiation. This occurred when radiation is administered both as a single dose (12 Gy) and in a multifraction regimen (5x3 Gy). A study of the scheduling of Banoxantrone (AQ4N) administration shows that there is a very long time period over which a maximal effect can be elicited (drug given 4 days before to 6 h after radiation). These results suggest that Banoxantrone has significant potential as a bioreductive drug[1]. The activation of banoxantrone cytotoxicity in vivo requires tumor hypoxia that is more extensive or prolonged than can readily be achieved by vasodilation or by antiangiogenic drug treatment[2]. Incorporation of banoxantrone into conventional chemoradiation protocols therefore targets both oxygenated and hypoxic regions of tumors, and potentially will increase the effectiveness of therapy. A single dose of 60 mg/kg banoxantrone enhances the response of RT112 (bladder) and Calu-6 (lung) xenografts to treatment with cisplatin and radiation therapy. Banoxantrone will increase the efficacy of chemoradiotherapy in preclinical models[3].
IC 50
Topoisomerase II
storage
Store at +4°C
Banoxantrone (dihydrochloride) Preparation Products And Raw materials
Raw materials
Preparation Products
Banoxantrone (dihydrochloride) Suppliers
- Tel
- 025-83697070
- Fax
- +86-25-83453306
- info@chemlin.com.cn
- Country
- China
- ProdList
- 16077
- Advantage
- 64
- Tel
- 1-631-485-4226; 16314854226
- info@bocsci.com
- Country
- United States
- ProdList
- 12952
- Advantage
- 65
- Tel
- 021-58955995
- Fax
- 609-228-5909
- sales@medchemexpress.cn
- Country
- United States
- ProdList
- 4861
- Advantage
- 58
- Tel
- 15221275939
- Fax
- 021-50706099
- shenlinxing@macklin.cn
- Country
- China
- ProdList
- 15873
- Advantage
- 55
- Tel
- 021-61312847; 18021002903
- Fax
- QQ:3008007432
- 3008007409@qq.com
- Country
- China
- ProdList
- 71826
- Advantage
- 60
- Tel
- 010-62971590 18548936886
- Fax
- 010-62340519
- 3462612863@qq.com
- Country
- China
- ProdList
- 10063
- Advantage
- 58
- Tel
- +1-781-999-5354; +17819995354
- marketing@targetmol.com
- Country
- United States
- ProdList
- 32435
- Advantage
- 58
- Tel
- +1-708-310-1919 +1-13798911105
- Fax
- 708-557-7486
- sales@invivochem.cn
- Country
- United States
- ProdList
- 6391
- Advantage
- 58
- Tel
- 18818260767
- Fax
- QQ 3610331285
- sales@chemegen.com
- Country
- China
- ProdList
- 11218
- Advantage
- 58
- Tel
- 88888888888
- hongquchem@qq.com
- Country
- China
- ProdList
- 5132
- Advantage
- 58